Spain
Industry
BMI View: Reinforcing BMI's view that companies with significant exposure to debt-ridden European markets will be hard hit by government austerity measures across the region, and in...
2012-01-20Industry
BMI Core View: Governments will increasingly impose price controls on pharmaceuticals. Drugmakers have generally charged what the market will bear in both developed and emerging markets....
2012-01-04Industry
BMI View: We believe the Spanish government's decision to implement further austerity measures is a necessary and prudent course of action. The country still has the third highest budget...
2012-01-03Finance
BMI View: The delay in public hospital payments to drugmakers threatens Spain's attractiveness as a location in which to sell drugs and medical devices, especially as public health...
2011-10-11Industry
BMI View: The delay in public hospital payments to drugmakers threatens Spain's attractiveness as a location in which to sell drugs and medical devices, especially as public health...
2011-10-11Industry
BMI View: We believe the Spanish government's decision to implement further austerity measures is a necessary and prudent course of action. The country still has the third highest budget...
2011-07-25Industry
BMI view: Deficits remain a key challenge for the majority of governments across Europe. While many sectors may see only limited downside risks from the situation, the pharmaceutical...
2011-07-25Industry
BMI View: The delay in public hospital payments to drugmakers threatens Spain's attractiveness as a location in which to sell drugs and medical devices, especially as public health...
2011-06-13
